Researchers uncover why the TP53 gene is especially prone to mutations in cancer

Mutations in the fragile TP53 gene impair p53’s tumor-suppressive functions, making it more vulnerable than other tumor suppressors.

Subclinical Afib Caught on Cardiac Devices Might Be Better Left Alone

AMSTERDAM — Edoxaban (Savaysa) didn’t improve outcomes for high-risk patients with subclinical atrial fibrillation (Afib)-like episodes detected by implanted cardiac devices, the NOAH-AFNET 6 trial

August 26, 2023

Sonar Secures $2.4M for AI-Powered Mental Health Platform for Teens

What You Should Know: – Sonar Mental Health (“Sonar”), an AI-powered mental health platform helping young people thrive, today announces $2.4M in pre-seed funding led

February 25, 2025

Off-the-shelf and on the decline: Adicet Bio’s shares halved after PhI look at cell therapy

Adicet Bio’s stock price was halved on Tuesday morning as investors tanked the biotech’s shares $ACET following a look at Phase I data on its

June 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.